Olmesartan Medoxomilo Krka

Olmesartan medoxomil, the active ingredient in Olmesartan Medoxomilo Krka, is an angiotensin II receptor blocker presented as a tablet for oral use. It is employed in the management of hypertension in adult patients. GNH USA supplies Olmesartan Medoxomilo Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Olmesartan Medoxomilo Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Olmesartan medoxil is indicated for conditions that involve the renin‑angiotensin system, particularly high blood pressure.

- Hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Heart failure: used as part of combination therapy to improve cardiac output and symptoms. - Diabetic nephropathy: helps slow progression of kidney damage by controlling blood pressure. - Post‑myocardial infarction: contributes to secondary prevention by maintaining lower blood pressure. - Chronic kidney disease: assists in preserving renal function through blood‑pressure control.

Olmesartan medoxil may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Dizziness or light‑headed  - Headache  - Fatigue  - Nasal congestion  - Diarrhea  - Cough

Serious or Rare Side Effects: - Angio‑edema  - Severe hypotension  - Acute kidney injury  - Hyperkalemia  - Liver enzyme elevation  - Allergic skin reactions such as Stevens‑Johnson syndrome

When using Olmesartan medoxil, several safety considerations should be observed.

- Monitor blood pressure: ensure therapeutic targets are achieved without excessive lowering. - Assess renal function: periodic testing is advised, especially in patients with pre‑existing kidney disease. - Check electrolytes: watch for elevated potassium levels. - Avoid use in pregnancy: drug is contraindicated due to risk of fetal toxicity. - Review concomitant medications: assess for additive blood‑pressure‑lowering effects. - Store at below 25°C: keep in the original packaging "​

Olmesartan medoxil interacts  g  g 

--- 

     t  t

    """"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""